Skip to main content
PBH logo

PBH

Prestige Consumer Healthcare Inc.
$50.42 +1.56 (+3.19%) At close · Jul 7
Market Cap
$2.39B
Shares
47,372,166

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$1.09B -4.3%
FY2026 Revenue FY2010–FY2026
Net Income
$190.3M -11.3%
FY2026 Net Income FY2010–FY2026
Gross Margin
54.71% -1pp
FY2026 Gross Margin FY2010–FY2026
Operating Margin
28.42% -1.2pp
FY2026 Operating Margin FY2010–FY2026
Diluted EPS
$3.91 -8.9%
FY2026 Diluted EPS FY2010–FY2026
Operating Cash Flow
$257.63M +2.4%
FY2026 Operating Cash Flow FY2010–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
$1.09B $1.14B $1.13B $1.13B $1.09B $943.37M $963.01M $975.78M $1.04B $882.06M $806.25M $713.46M $595.64M $616.92M $441.09M $336.51M $292.6M
-$42.34M -$47.63M -$67.16M -$69.16M -$64.29M
$493.13M $503.3M $500.91M $502.43M $466.17M $395.89M $410.79M $420.2M $464.67M $381.77M $339.04M
$595.58M $634.46M $624.45M $625.29M $620.65M $547.47M $552.22M $555.58M $576.51M $500.29M $467.21M $406.22M $335.55M $343.74M $227.38M $170.88M $153.44M
54.71% 55.76% 55.49% 55.45% 57.11% 58.03% 57.34% 56.94% 55.37% 56.72% 57.95% 56.94% 56.33% 55.72% 51.55% 50.78% 52.44%
$116.45M $108.21M $106.15M $107.35M $107.46M $83.11M $89.11M $89.76M $85.39M $89.11M $72.42M $81.27M $48.48M $51.47M $56.7M $41.96M $34.2M
$17.92M $18.26M $19.78M $22.27M $21.5M $19.58M $19.63M $21.77M $23.35M $19.75M $18.43M $13M $10.26M $11.68M $9.99M $9.21M
$31.27M $30.17M $30.68M $32.63M $32.09M $30.16M $29M $31.78M $33.43M $25.79M $23.68M $17.74M $13.49M $13.24M $10.73M $10.11M $11.45M
$286.17M $297.69M $282.02M $647.71M $290.73M $250.07M $261.07M $488.07M $361.03M $294.64M $206.9M $198.66M $146.94M $151.85M $124.56M $94.73M $75.12M
$309.41M $336.78M $342.43M -$22.42M $329.92M $297.4M $291.16M $67.5M $215.47M $205.64M $260.32M $207.56M $188.62M $191.88M $102.82M $76.15M $78.33M
28.42% 29.6% 30.43% -1.99% 30.36% 31.53% 30.23% 6.92% 20.7% 23.31% 32.29% 29.09% 31.67% 31.1% 23.31% 22.63% 26.77%
$340.68M $366.95M $373.1M $10.21M $362.01M $327.57M $320.15M $99.28M $248.9M $231.44M $283.99M $225.3M $202.1M $205.12M $113.56M $86.25M $89.78M
$1.8M $5.2M $4.4M
$323K $342K $217K $388K $203K $162K $92K $60K $13K $18K $1000 $1000
-$9.57M -$4.95M $756K -$2.34M -$1.05M $1.37M -$1.63M -$476K $392K -$30K
$257.5M $284.19M $276.03M -$93.92M $262.46M $204.11M $191.15M -$38.06M $107.09M $110.85M $157.19M $127.46M $101.75M $106.03M $61.16M $48.53M $52.73M
$67.2M $69.58M $66.69M -$11.61M $57.08M $39.43M $48.87M -$2.26M -$232.48M $41.46M $57.28M $49.2M $29.13M $40.53M $23.95M $19.35M $20.66M
$190.3M $214.6M $209.3M -$82.3M $205.4M $164.68M $142.28M -$35.8M $339.57M $69.4M $99.91M $78.26M $72.62M $65.51M $37.21M $29.22M $32.12M
17.48% 18.86% 18.6% -7.3% 18.9% 17.46% 14.77% -3.67% 32.61% 7.87% 12.39% 10.97% 12.19% 10.62% 8.44% 8.68% 10.98%
$199.59M $211.44M $206.41M -$94.84M $206.15M $189.04M $123.87M -$42.23M $346.61M $66.57M $99.79M $54.11M $73.46M $65.41M $37.2M $29.22M $33.45M
USD/shares $3.93 $4.32 $4.21 -$1.65 $4.09 $3.28 $2.81 -$0.69 $6.40 $1.31 $1.89 $1.50 $1.41 $1.29 $0.74 $0.58 $0.64
USD/shares $3.91 $4.29 $4.17 -$1.65 $4.04 $3.25 $2.78 -$0.69 $6.34 $1.30 $1.88 $1.49 $1.39 $1.27 $0.73 $0.58 $0.64
shares 48.46M 49.7M 49.76M 49.89M 50.26M 50.21M 50.72M 52.07M 53.1M 52.98M 52.75M 52.17M 51.64M 50.63M 50.27M 50.08M 50.01M
shares 48.72M 50.08M 50.18M 49.89M 50.84M 50.61M 51.14M 52.07M 53.53M 53.36M 53.14M 52.67M 52.35M 51.44M 50.75M 50.34M 50.09M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2013–FY2026: $401.36M in buybacks, $0 in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
EV/EBIT
P/E (TTM)
12.90×
Drug Manufacturers - Specialty & Generic median 21.31×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
North American OTC Healthcare $913,576,000 $960,010,000 $958,260,000 $973,774,000 $967,881,000 $849,319,000 $859,368,000 $862,446,000
International OTC Healthcare $175,129,000 $177,752,000 $167,097,000 $153,951,000 $118,931,000 $94,046,000 $103,642,000 $93,520,000
Household Cleaning $19,811,000

By Geography (USD)

Component 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
United States $850,414,000 $897,540,000 $886,470,000 $953,222,000 $910,106,000 $799,038,000 $812,653,000 $837,049,000
Non Us $238,291,000 $240,222,000 $238,887,000 $174,503,000 $176,706,000 $144,327,000 $150,357,000 $138,728,000

By Product & Service (USD)

Component 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Product $1,084,744,000 $1,136,581,000 $1,125,046,000 $1,127,618,000 $1,086,770,000 $943,324,000 $962,936,000 $975,692,000
Gastrointestinal $259,788,000 $255,943,000 $231,610,000 $226,583,000 $204,559,000 $161,136,000 $172,908,000 $160,462,000
Womens Health $227,765,000 $236,831,000 $240,421,000 $251,351,000 $264,509,000 $268,097,000 $251,551,000 $258,479,000
Eye and Ear Care $142,939,000 $183,322,000 $179,423,000 $171,076,000 $163,449,000 $110,409,000 $112,156,000 $112,837,000
Dermatologicals $125,931,000 $128,947,000 $129,102,000 $123,741,000 $120,386,000 $107,083,000 $103,012,000 $97,972,000
Analgesics $113,936,000 $117,697,000 $117,451,000 $119,262,000 $119,323,000 $119,142,000 $114,007,000 $114,178,000
Cough and Cold $101,909,000 $106,214,000 $119,020,000 $126,988,000 $107,080,000 $70,641,000 $111,106,000 $103,123,000
Oral Care $101,051,000 $95,030,000 $96,305,000 $97,627,000 $97,521,000 $101,431,000 $93,205,000 $103,432,000
Other Otc $15,386,000 $13,778,000 $12,025,000 $11,097,000 $9,985,000 $5,426,000 $5,065,000 $5,483,000
Product And Service Other $3,961,000 $1,181,000 $311,000 $107,000 $42,000 $41,000 $74,000 $85,000
Household Cleaning Department $0 $19,811,000
Key facts CIK 1295947 CUSIP 74112D101 13F (30d) 13 filings 10 filers Visit website Investor relations